Literature DB >> 29945212

Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?

K A A Fox1, J W Eikelboom2, S S Anand2, D L Bhatt3, J Bosch2, S J Connolly2, R A Harrington4, P G Steg5, S Yusuf2.   

Abstract

Entities:  

Year:  2019        PMID： 29945212     DOI： 10.1093/eurheartj/ehy347

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  1 in total

1.  Commentary: It looks good, but will it last?

Authors:  Rachel Eikelboom; Michael H Yamashita
Journal:  JTCVS Open       Date:  2020-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.